Addex to Present at the Cantor Global Healthcare 2021 Conference
Geneva, Switzerland, September 29, 2021 – Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric…
Month: September 2021
Addex Therapeutics Initiates Phase 2 Clinical Study with Dipraglurant in Blepharospasm
Type of dystonia characterized by involuntary spasms of the eyelid muscles can lead to substantial…
Acacia Pharma Announces Submission and Validation of Marketing Authorization Application for BARHEMSYS® (amisulpride injection) in Major European Markets
This announcement contains inside information for the purposes of Article 7 of the Market Abuse…
Celldex Presents Positive Data on Symptom Control and Quality of Life Measurements that Further Support CDX-0159 Clinical Benefit in Phase 1b Study in Chronic Inducible Urticaria at EADV 2021
– Rapid and sustained improvement in urticaria control after single dose of CDX-0159 –– Greatly…
HUTCHMED Highlights Oral Presentations at 2021 Chinese Society of Clinical Oncology Annual Meeting
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Sept. 28, 2021 (GLOBE NEWSWIRE) —…
HUTCHMED Announces Closing of Divestment of Non-Core OTC Joint Venture
HONG KONG and FLORHAM PARK, N.J., Sept. 29, 2021 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited…
PharmaTher Announces Closing of CAD$10 Million Private Placement with Institutional Investors
TORONTO, Sept. 28, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (CSE:…
Iovance Biotherapeutics Celebrates Grand Opening of Iovance Cell Therapy Center (iCTC) in the Philadelphia Navy Yard
Ribbon Cutting to be Led by Patient Advocacy Organizations, Caregivers, and Key Stakeholders Largest and…
Genocea to Present at Upcoming Conferences
CAMBRIDGE, Mass., Sept. 28, 2021 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical…
Vaxcyte to Present at Guggenheim 2nd Annual Vaccine and Infectious Disease Conference
FOSTER CITY, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation…
Terns Appoints Veteran Biopharmaceutical Executive Ann E. Taylor, M.D. to Board of Directors
FOSTER CITY, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
Satsuma Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA),…
Wave Life Sciences Announces New Data for Leading RNA Editing Capability Across Multiple Tissues and Provides Update on AATD Program During Analyst and Investor Research Webcast
Durable ADAR editing in vivo in preclinical models, including in CNS tissues with editing out…
Arcutis Expands Patent Portfolio with Roflumilast Pharmacokinetics Patent
WESTLAKE VILLAGE, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage…
ERYTECH to Participate in the HealthTech Innovation Days (HTID) by France Biotech
ERYTECH to Participate in the HealthTech Innovation Days (HTID) by France Biotech Cambridge, MA (U.S.)…
FDA Grants Catalyst Biosciences Orphan Drug Designation for MarzAA for the Treatment of Factor VII Deficiency
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO)…
Inventiva announces participation at several investor conferences in October 2021
Daix (France), Long Island City (New York, United States), September 28, 2021 – Inventiva (Euronext…
CORRECTION – Sorrento Therapeutics, Inc.
SAN DIEGO, Sept. 28, 2021 (GLOBE NEWSWIRE) — In a release issued on Tuesday, September 28th by Sorrento…
AB Science receives regulatory authorization to commence a second Phase 2 Covid-19 study
PRESS RELEASE AB SCIENCE RECEIVES REGULATORY AUTHORIZATION TO COMMENCE A SECOND PHASE 2 COVID STUDY…
Sorrento to Participate in the Benzinga Healthcare Small Cap Conference on September 30th
SAN DIEGO, Sept. 28, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”) is…